SFO
ALXN

Standard Family Office’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Standard Family Office’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-12
Closed -$2K – 561
2021
Q2 		$2K Hold
12
– – ﹤0.01% 457
2021
Q1 		$2K Hold
12
– – ﹤0.01% 486
2020
Q4 		$2K Buy
+12
New +$2K ﹤0.01% 528